Activation induced deaminase mutational signature overlaps with CpG methylation sites in follicular lymphoma and other cancers

Igor B. Rogozin, Artem G. Lada, Alexander Goncearenco, Michael R. Green, Subhajyoti De, German Nudelman, Anna R. Panchenko, Eugene V. Koonin, Youri I. Pavlov

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Follicular lymphoma (FL) is an uncurable cancer characterized by progressive severity of relapses. We analyzed sequence context specificity of mutations in the B cells from a large cohort of FL patients. We revealed substantial excess of mutations within a novel hybrid nucleotide motif: the signature of somatic hypermutation (SHM) enzyme, Activation Induced Deaminase (AID), which overlaps the CpG methylation site. This finding implies that in FL the SHM machinery acts at genomic sites containing methylated cytosine. We identified the prevalence of this hybrid mutational signature in many other types of human cancer, suggesting that AID-mediated, CpG-methylation dependent mutagenesis is a common feature of tumorigenesis.

Original languageEnglish (US)
Article number38133
JournalScientific reports
Volume6
DOIs
StatePublished - Dec 7 2016

    Fingerprint

ASJC Scopus subject areas

  • General

Cite this

Rogozin, I. B., Lada, A. G., Goncearenco, A., Green, M. R., De, S., Nudelman, G., Panchenko, A. R., Koonin, E. V., & Pavlov, Y. I. (2016). Activation induced deaminase mutational signature overlaps with CpG methylation sites in follicular lymphoma and other cancers. Scientific reports, 6, [38133]. https://doi.org/10.1038/srep38133